News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Alex Bataller: Phase 1/2 trial results of oral decitabine/cedazuridine with venetoclax in higher risk MDS and CMML
Photo of Alex Bataller/LinkedIn
Feb 15, 2024, 18:42

Alex Bataller: Phase 1/2 trial results of oral decitabine/cedazuridine with venetoclax in higher risk MDS and CMML

Alex Bataller, Leukemia fellow at Leukemia Department, MD Anderson Cancer Center (Houston, Texas), shared a post on X/Twitter:

”Delighted to announce our newest publication in The Lancet Haematology of the phase 1/2 trial results of oral decitabine/cedazuridine with venetoclax in higher risk MDS and CMML.

This totally oral combination had an acceptable toxicity profile with an encouraging ORR of 95% and 49% of patients undergoing subsequent HSCT.”

Alex Bataller: Phase 1/2 trial results of oral decitabine/cedazuridine with venetoclax in higher risk MDS and CMML

Source: Alex Bataller/X

Alex Bataller cancer MDS and CMML OncoDaily Oncology oral decitabine/cedazuridine with venetoclax The Lancet Haematology Toxicity Profile
Special Coverage
Blog
Nov 21, 2024, 10:02
Staying current on cutting edge research into genetic/familial high-risk assessment - NCCN
Blog
Nov 21, 2024, 09:55
New Hope for Mantle Cell Lymphoma Patients - The Babak Lab
Blog
Nov 21, 2024, 09:28
Championing Children’s Health event at the European Parliament! - SIOP Europe
Blog
Nov 21, 2024, 09:23
Sachin H. Jain: Timeless lessons my father taught me about healthcare
Positive
Nov 21, 2024, 09:18
Vivek Subbiah: Delighted to welcome Krish Patel as our new lymphoma leader SCRI
Blog
Nov 21, 2024, 09:04
Tracey O'Brien: Lung cancer doesn’t discriminate
Blog
Nov 21, 2024, 06:52
Sylvester’s third annual Art is Medicine exhibit's new theme is "The Bridge to Bahia"
Blog
Nov 21, 2024, 06:49
OncoInfluencers to Follow on Social Media: Dr. Melvin L.K. Chua
Blog
Nov 21, 2024, 06:44
Hedley Lewis: Gratitude to all The Cows who participated in the Virgin Active South Africa Ride Joburg
Insight
Nov 21, 2024, 06:29
Sami Mansfield: What if improving metabolic health could reduce cancer risks and improve outcomes?
Blog
Nov 21, 2024, 06:27
Julie Gralow: Comprehensive Genomic Profiling Improves Precision Therapy Use And Patient Survival
Insight
Nov 20, 2024, 20:44
Baris Turkbey: Excited to announce NCI Molecular Imaging members presenting their research at RSNA2024